Effects of Neuromuscular Electrical Stimulation on Critically Ill Patients With Mechanical Ventilation
1 other identifier
interventional
47
1 country
1
Brief Summary
Up to 25% of patients who require mechanical ventilation (MV) more than seven days in the intensive care unit (ICU) develop muscle weakness, which comprises deep muscle weakness , including the respiratory muscles.Early active mobilization in ICU patients is a safe and viable strategy to prevent the physical problems caused by immobility. Neuromuscular electrical stimulation (NMES) is an alternative to mobilize and exercise because it does not require active patient participation and can be used on bedridden patients.No previous studies have shown whether training-specific respiratory muscles using an electrical stimulation can have overall benefits for ICU patients on MV.For this reason, the aim of this study was to evaluate, the effectiveness of the NMES therapy combined with early rehabilitation in the respiratory muscles of patients on MV.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 8, 2022
CompletedFirst Posted
Study publicly available on registry
February 1, 2022
CompletedStudy Start
First participant enrolled
February 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2022
CompletedMarch 2, 2022
February 1, 2022
7 months
January 8, 2022
February 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
diaphragmatic thickening fraction(DTF)
DTF shows varied thickness of the diaphragm at end-expiration and end-inspiration. Te maximum and minimum values of each breathing cycle were taken as the end-inspiratory diaphragm thickness (DTei) and the end-expiratory diaphragm thickness (DTee), respectively. DTF was calculated by DTF=(DTei DTee)/DTee 100%. Te values for 3 consecutive respiratory cycles were recorded and the average value was taken as the fnal value
baseline,Day 3 of mechanical ventilation,Day 7 of mechanical ventilation,before extubation
Secondary Outcomes (1)
Parasternal Intercostal Muscle Ultrasound
baseline,Day 3 of mechanical ventilation,Day 7 of mechanical ventilation,before extubation
Other Outcomes (1)
ventilator-free days at 28 days
28 days
Study Arms (2)
NMSE Group
EXPERIMENTALNeuromuscular Electrical Stimulation(NMES) group received consecutive daily sessions of electrical stimulation at specific points starting on the first day of randomization.The subjects also receive conventional physical therapy, which included gross motor therapy and respiratory therapy twice a day every day during their stay in the ICU.
CPT group
NO INTERVENTIONThe subjects only receive conventional physical therapy, which included gross motor therapy and respiratory therapy twice a day every day during their stay in the ICU.
Interventions
NMES was performed using a portable machine.The negative electrodes were placed in the motor points of the following muscles: chest muscles (pectoralis major muscle fibres) and rectus abdominis muscles bilaterally. A second (positive) electrode was positioned distally to the first, at a site close to the muscle that was being electrically stimulated, totalling 1 channel with 2 electrodes for each muscle . Each NMES session lasted 30 min. The following parameters were used: 50 Hz frequency, pulse duration 300 ms, rise time 1 s, stimulus time (ON) 3 s, decay time 1 s, and relaxation time (OFF) 10 s. Intensity was increased until muscle contraction was visible or could be identified through palpation. In conscious patients, intensity was adjusted according to their tolerance.
Eligibility Criteria
You may qualify if:
- Prolonged MV(\>72 h);
- Written informed consent was obtained from the patients or their relatives
You may not qualify if:
- Previous neuromuscular disease;
- Unrelieved pneumothorax, restricted diaphragmatic dyskinesia including abdominal high pressure, a large number of ascites
- Thoracic or diaphragmatic malformation;
- Local skin damage and infection;
- Indwelling a temporary or permanent pacemaker;
- Severe obesity(BMI\>35 kg/m2)
- Various reasons (severe intestinal gas accumulation, structural abnormalities) lead to the failure of ultrasonic detection of diaphragm movement;
- Patients with an expected survival time of less than 7 days or with palliative care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Neuromuscular electrical stimulation
Qingdao, 266003, China
Study Officials
- STUDY DIRECTOR
Jinyan Xing, Dr.
The Affiliated Hospital of Qingdao University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
January 8, 2022
First Posted
February 1, 2022
Study Start
February 1, 2022
Primary Completion
August 31, 2022
Study Completion
August 31, 2022
Last Updated
March 2, 2022
Record last verified: 2022-02